Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2026 07:01 ET | Source: Research and Markets

Low-Grade Glioma Market Trends and Investment Opportunities Through 2030 & 2035: Regional Insights for Trametinib, Dabrafenib, Ivosidenib, and Mirdametinib

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Low-Grade Glioma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global low-grade glioma market is experiencing a...
March 31, 2026 07:20 ET | Source: Research and Markets

Oncologists Industry to Grow by $4 Billion Globally During 2026-2030: Assessment of the Lucrative Trends and Opportunities by Region

Dublin, March 31, 2026 (GLOBE NEWSWIRE) -- The "Oncologists Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides comprehensive statistics, including global...
March 30, 2026 05:58 ET | Source: Research and Markets

Carcinoid Tumor Market to Rise at 10.1% CAGR During 2026-2030: Increasing Obesity Rates Spur Growth

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Carcinoid Tumor Market Report 2026" has been added to ResearchAndMarkets.com's offering.The global carcinoid tumor market is rapidly expanding, with...
March 30, 2026 05:57 ET | Source: Research and Markets

Cutaneous Squamous Cell Carcinoma (cSCC) Market Rises to $8.33 Billion in 2026: Roche, Merck & Co., and Sanofi Leads the Industry

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Cutaneous Squamous Cell Carcinoma (cSCC) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The cutaneous squamous cell...
March 30, 2026 05:15 ET | Source: Research and Markets

Trends and Opportunities in the Chemotherapy-At-Home Services Market, 2026-2030: Total Revenue to Grow by $1 Billion, Led by CVS Health, Optum, and Fresenius Kabi

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Chemotherapy At Home Services Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers a comprehensive analysis,...
March 30, 2026 05:13 ET | Source: Research and Markets

Cancer Cachexia Market Outlook Report 2026-2030: Personalized Treatments and Digital Tools Elevate Cancer Cachexia Care; Total Revenue to Grow by $600 Million

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides critical insights, including market size...
March 30, 2026 04:28 ET | Source: Research and Markets

Cancer Clinical Decision Tools Market to Grow by $280 Million During 2026-2030: Key Growth Areas & Competitive Strategies Identified

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Cancer Clinical Decision Tools Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global cancer clinical decision tools...
March 27, 2026 10:55 ET | Source: Research and Markets

Vulvar Cancer Market Size to Grow by $270 Million During 2026-2030: Investments and Personalized Medicine Drive Market Expansion

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Vulvar Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering.The vulvar cancer market has seen significant growth and is...
March 27, 2026 10:39 ET | Source: Research and Markets

Clinical Nutrition for Cancer Care: 2026-2030 Market Analysis Featuring Profiles of Leading Players - Abbott Nutrition, Baxter International, B Braun Melsungen, Nestle Health Science, Danone Nutricia and More

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Clinical Nutrition for Cancer Care Market Report 2026" has been added to ResearchAndMarkets.com's offering. The clinical nutrition for cancer...
March 26, 2026 16:30 ET | Source: Onco360 Oncology Pharmacy

Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant)

LOUISVILLE, Ky., March 26, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Corcept Therapeutics for...